Phillip M Kemp-Bohan

8PUBLICATIONS
6CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyComposite and hybrid materialsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Oct 06, 2023
Predictors and benefits of multiagent chemotherapy for pancreatic adenocarcinoma: Timing matters.

Franklin A Valdera, Anne E O'Shea, Todd R Smolinsky

|Dec 08, 2022
ASO Author Reflections: The Complexity of the Volume-Outcome Relationship in Pancreatic Cancer.

Phillip M Kemp Bohan, Daniel W Nelson

|Jul 09, 2021
Impact of dermal matrix thickness on split-thickness skin graft survival and wound contraction in a single-stage procedure.

Phillip M Kemp Bohan, Laura E Cooper, John L Fletcher

|Feb 10, 2021
Rates, Predictors, and Outcomes of Portal Lymphadenectomy for Resectable Gallbladder Cancer.

Phillip M Kemp Bohan, Anne E O'Shea, Oriana V Ellis

|Feb 09, 2021
ASO Author Reflections: Contemporary Analysis of Impact of Lymphadenectomy on Survival in Nonmetastatic Gallbladder Cancer.

Phillip M Kemp Bohan, Daniel W Nelson, Timothy J Vreeland

|Jan 30, 2021
Phase I Trial of Encapsulated Rapamycin in Patients with Prostate Cancer Under Active Surveillance to Prevent Progression.

Phillip M Kemp Bohan, Robert C Chick, Anne E O'Shea

Pageof 2